- AVEO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Aveo Pharmaceuticals (AVEO) S-3Shelf registration
Filed: 27 Dec 11, 12:00am
Exhibit 12.1
STATEMENT REGARDING COMPUTATION OF CONSOLIDATED RATIO/DEFICIENCY OF
EARNINGS TO FIXED CHARGES
(dollars in thousands)
Nine Months Ended September 30, 2011 | Fiscal Year Ended December 31, | 2006 | ||||||||||||||||||||||
2010 | 2009 | 2008 | 2007 | |||||||||||||||||||||
Fixed charges: | ||||||||||||||||||||||||
Interest expense on indebtedness | $ | 2,256 | $ | 2,537 | $ | 2,125 | $ | 1,610 | $ | 1,886 | $ | 1,359 | ||||||||||||
Noncash interest expense and other | 655 | 1,434 | 686 | 725 | 552 | 232 | ||||||||||||||||||
Interest expense on portion of rent expense representative of interest | 317 | 352 | 351 | 327 | 317 | 317 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Total fixed charges | $ | 3,228 | $ | 4,323 | $ | 3,162 | $ | 2,662 | $ | 2,755 | $ | 1,908 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Earnings (loss): | ||||||||||||||||||||||||
Net income (loss) before benefit for income taxes | $ | 55,817 | $ | (58,789 | ) | $ | (44,193 | ) | $ | (32,473 | ) | $ | (24,982 | ) | $ | (24,905 | ) | |||||||
Fixed charges per above | 3,228 | 4,323 | 3,162 | 2,662 | 2,755 | 1,908 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Total earnings (loss) | $ | 59,045 | $ | (54,466 | ) | $ | (41,031 | ) | $ | (29,811 | ) | $ | (22,227 | ) | $ | (22,997 | ) | |||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Ratio of earnings to fixed charges | 18.3 | — | — | — | — | — | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Deficiency of earnings available to cover fixed charges | — | $ | (58,789 | ) | $ | (44,193 | ) | $ | (32,473 | ) | $ | (24,982 | ) | $ | (24,905 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|